The Copenhagen Triage Algorithm is non-inferior to a traditional triage algorithm: A cluster-randomized study.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
01
02
2018
accepted:
19
01
2019
entrez:
5
2
2019
pubmed:
5
2
2019
medline:
7
11
2019
Statut:
epublish
Résumé
Triage systems with limited room for clinical judgment are used by emergency departments (EDs) worldwide. The Copenhagen Triage Algorithm (CTA) is a simplified triage system with a clinical assessment. The trial was a non-inferiority, two-center cluster-randomized crossover study where CTA was compared to a local adaptation of Adaptive Process Triage (ADAPT). CTA involves initial categorization based on vital signs with a final modification based on clinical assessment by an ED nurse. We used 30-day mortality with a non-inferiority margin at 0.5%. Predictive performance was compared using Receiver Operator Characteristics. We included 45,347 patient visits, 23,158 (51%) and 22,189 (49%) were triaged with CTA and ADAPT respectively with a 30-day mortality of 3.42% and 3.43% (P = 0.996) a difference of 0.01% (95% CI: -0.34 to 0.33), which met the non-inferiority criteria. Mortality at 48 hours was 0.62% vs. 0.71%, (P = 0.26) and 6.38% vs. 6.61%, (P = 0.32) at 90 days for CTA and ADAPT. CTA triaged at significantly lower urgency level (P<0.001) and was superior in predicting 30-day mortality, Area under the curve: 0.67 (95% CI 0.65-0.69) compared to 0.64 for ADAPT (95% CI 0.62-0.66) (P = 0.03). There were no significant differences in rate of admission to the intensive care unit, length of stay, waiting time nor rate of readmission within 30 or 90 days. A novel triage system based on vital signs and a clinical assessment by an ED nurse was non-inferior to a traditional triage algorithm by short term mortality, and superior in predicting 30-day mortality. Clinicaltrials.gov NCT02698319.
Identifiants
pubmed: 30716123
doi: 10.1371/journal.pone.0211769
pii: PONE-D-18-02656
pmc: PMC6361446
doi:
Banques de données
ClinicalTrials.gov
['NCT02698319']
Types de publication
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0211769Déclaration de conflit d'intérêts
Dr. Torp-Pedersen reports grants and personal fees from Bayer, grants from Biotronic, outside the submitted work.
Références
Scand J Trauma Resusc Emerg Med. 2011 Jun 30;19:42
pubmed: 21718476
Emerg Med J. 2010 Feb;27(2):86-92
pubmed: 20156855
Scand J Trauma Resusc Emerg Med. 2016 Oct 10;24(1):123
pubmed: 27724978
PLoS One. 2014 Jul 14;9(7):e101739
pubmed: 25019354
Emerg Med (Fremantle). 2003 Feb;15(1):6-10
pubmed: 12656779
Eur J Emerg Med. 2007 Dec;14(6):324-31
pubmed: 17968197
Acad Emerg Med. 2000 Mar;7(3):236-42
pubmed: 10730830
Ann Emerg Med. 2008 Aug;52(2):126-36
pubmed: 18433933
Clin Epidemiol. 2015 Nov 17;7:449-90
pubmed: 26604824
Scand J Trauma Resusc Emerg Med. 2012 Apr 10;20:28
pubmed: 22490208
J Nurs Scholarsh. 2014 Mar;46(2):106-15
pubmed: 24354886
Scand J Trauma Resusc Emerg Med. 2015 Dec 01;23:106
pubmed: 26626588
Scand J Trauma Resusc Emerg Med. 2011 Dec 08;19:72
pubmed: 22151969
Scand J Trauma Resusc Emerg Med. 2012 Apr 10;20:29
pubmed: 22490233
Acad Emerg Med. 1999 Nov;6(11):1166-71
pubmed: 10569391
Acad Emerg Med. 2011 Aug;18(8):822-9
pubmed: 21843217